...
首页> 外文期刊>Vaccine >A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine
【24h】

A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine

机译:一项日本研究,评估伤寒Vi多糖疫苗的免疫原性和安全性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Although typhoid fever is rare in Japan, imported cases have been reported occasionally in travelers returning from endemic areas. To achieve licensing of a typhoid Vi polysaccharide vaccine (Typhim Vi (R)) and make it widely available in Japan, this study was conducted at the request of the Japanese Ministry of Health Labor and Welfare to assess the immunogenicity and safety of this vaccine when given as a single dose (the recommended schedule of administration) in a Japanese population.
机译:背景:虽然伤寒在日本很少见,但从流行地区返回的旅行者中偶尔也有进口病例的报道。为获得伤寒Vi多糖疫苗(Typhim Vi(R))的许可并使其在日本广泛使用,本研究是应日本厚生劳动省的要求进行的,以评估该疫苗的免疫原性和安全性。在日本人群中以单剂量(建议的给药时间表)给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号